These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8474373)

  • 41. Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study.
    Hema MN; Ferry T; Dupon M; Cuzin L; Verdon R; Thiébaut R; Protopopescu C; Leport C; Raffi F; Le Moing V;
    PLoS One; 2016; 11(8):e0161594. PubMed ID: 27548257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interventions for Increasing HIV Testing Uptake in Migrants: A Systematic Review of Evidence.
    Aung E; Blondell SJ; Durham J
    AIDS Behav; 2017 Oct; 21(10):2844-2859. PubMed ID: 28710710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Care of the newly-diagnosed HIV positive patient.
    Klaus BD
    Nurse Pract; 1994 Oct; 19(10):4, 7-8, 11. PubMed ID: 7816361
    [No Abstract]   [Full Text] [Related]  

  • 44. Intravenous gammaglobulin for pediatric HIV-1 infection. Effects on infectious complications, circulating immune complexes, and CD4 cell decline.
    Rubinstein A; Calvelli T; Rubinstein R
    Ann N Y Acad Sci; 1993 Oct; 693():151-7. PubMed ID: 7903518
    [No Abstract]   [Full Text] [Related]  

  • 45. MSMS offers a physician's guide to AIDS/HIV in Michigan.
    Lamberts MA
    Mich Med; 1990 Feb; 89(2):21. PubMed ID: 2308535
    [No Abstract]   [Full Text] [Related]  

  • 46. What is the future of GUM training?
    Mody N; Waters L; Richardson D
    Sex Transm Infect; 2016 Mar; 92(2):90. PubMed ID: 26892928
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of the general pediatrician in the management of human immunodeficiency virus infection in children.
    Rand TH; Meyers A
    Pediatr Rev; 1993 Oct; 14(10):371-9. PubMed ID: 8255817
    [No Abstract]   [Full Text] [Related]  

  • 48. Treating HIV infection without antiretrovirals; preventing HIV infection with them.
    Laurence J
    AIDS Read; 2004 Dec; 14(12):635-6. PubMed ID: 15619777
    [No Abstract]   [Full Text] [Related]  

  • 49. HIV testing in primary care: feasibility and acceptability of provider initiated HIV testing and counseling for sub-Saharan African migrants.
    Loos J; Manirankunda L; Hendrickx K; Remmen R; Nöstlinger C
    AIDS Educ Prev; 2014 Feb; 26(1):81-93. PubMed ID: 24450280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV/AIDS care at Tokyo Metropolitan Komagome Hospital.
    Negishi M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 2():S35-7. PubMed ID: 9070512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recovery of the immune system with antiretroviral therapy: the end of opportunism?
    Powderly WG; Landay A; Lederman MM
    JAMA; 1998 Jul; 280(1):72-7. PubMed ID: 9660367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preventing opportunistic infections in HIV-infected injection drug users.
    Perlman DC; Des Jarlais DC; Salomon N; Masson CL
    JAMA; 1997 Dec; 278(21):1743-4. PubMed ID: 9388148
    [No Abstract]   [Full Text] [Related]  

  • 53. Passive immunization for the treatment of HIV infection.
    Jacobson JM
    Mt Sinai J Med; 1998 Jan; 65(1):22-6. PubMed ID: 9458680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Asymptomatic HIV infection. A primary care disease.
    Jewell ME; Sweet DE
    Postgrad Med; 1992 Oct; 92(5):155-6, 159-62, 165-6. PubMed ID: 1409169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human immunodeficiency virus early intervention physician guidelines, second edition. Advisory Group on HIV Early Intervention, Second Edition, American Medical Association.
    Arch Fam Med; 1994 Nov; 3(11):988-102. PubMed ID: 7804482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.
    Lu W; Mehraj V; Vyboh K; Cao W; Li T; Routy JP
    J Int AIDS Soc; 2015; 18(1):20052. PubMed ID: 26130226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of recombinant interferon-alpha in human immunodeficiency virus (HIV)-infected individuals.
    Rivero J; Limonta M; Aguilera A; Fraga M; López Saura P
    Biotherapy; 1994; 8(1):23-31. PubMed ID: 7547078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term outcomes of a pediatric HIV treatment program in Maputo, Mozambique: a cohort study.
    Walter J; Molfino L; Moreno V; Edwards CG; Chissano M; Prieto A; Bocharnikova T; Antierens A; Lujan J
    Glob Health Action; 2015; 8():26652. PubMed ID: 26287397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-2 immunotherapy does not benefit patients taking antiretrovirals.
    AIDS Patient Care STDS; 2009 Mar; 23(3):221-2. PubMed ID: 19866543
    [No Abstract]   [Full Text] [Related]  

  • 60. Prioritizing HIV care and support interventions-moving from evidence to policy.
    Langley CL; Lapidos-Salaiz I; Hamm TE; Bateganya MH; Firth J; Wilson M; Martin J; Dierberg K
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3():S375-8. PubMed ID: 25768877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.